Skip to content Skip to navigation menu

MerMade 4 Column Positions (2020 Model)

MerMade 4 Column Positions (2020 Model)

The MerMade oligonucleotide synthesizer is designed to synthesize DNA, RNA and LNA oligonucleotides in column format using standard or modified chemistries.
  • 10 amidite positions
  • 50 nmol to 5 μmol scale synthesis
  • Flexible and easy to use software that runs on Windows 10
  • Run logging
  • Mixed backbone capability (phosphorothioate and phosphodiester)
  • Dell PC and monitor included with extended warranty
  • Pre-loaded with standard protocols
  • Cleavage apparatus included
  • UPS back up to allow synthesis recovery in the event of power loss (option)
  • Multiple reagent cap adapters (option)
  • Custom integration of software with in house LIMS (option)
Item ID AXM4
Enquire

Product information

The new MerMade oligonucleotide synthesizer, 2020 model, is designed to synthesize DNA, RNA and LNA oligonucleotides in column format using standard or modified chemistries. Each of the 4 columns within this synthesizer can be assigned a different protocol to permit synthesis of oligos of different quality and yield within the same run with scales varying from 50 nmole to 5 μmol. The synthesizer is optimised for fast synthesis cycles (20mer primers in 3 hours on each column) and during the run can be paused to allow removal or addition of columns while synthesizer is in operation. Oligos up to 150 bases in length have been made with a coupling efficiency in excess of 99%, making this perfect for applications such as - dye terminator sequencing reactions - gene building - polymerase chain reactions (PCR) - hybridisation - RT-PCR - anti-sense studies - siRNA - aptamers Priced to compete with other low-through-put machines on the market, the MerMade 4 is a great choice when looking for an easy to use low cost synthesizer.

Brand BioAutomation
Type Instruments
Synthesizer Model MerMade 4

Access support

Need some support with placing an order, setting up an account, or finding the right protocol?

Contact us